UNSPSC 51182711: Glimepiride/metformin

Glimepiride/metformin is a fixed-dose combination therapy of an agent of the biguanide class and a sulfonylurea used to treat high blood sugar levels caused by type 2 diabetes.

UNSPSC 51182711 Glimepiride/metformin, a Commodity code, shows no active state and local procurement activity grounded in the actual pharmaceutical product itself. The most recent opportunities in the dataset tagged under this code—including Seminole County's procurement of naloxone and drug deactivation systems (IFB, July 2026), the City of Tucson Fire Department's BLS/ALS pharmaceuticals and vending services (RFP, June 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's generic multi-source pharmaceuticals and OTC products (RFP, March 2026)—address emergency medical supplies, addiction-treatment products, and broad generic pharmaceutical categories respectively, none of which directly target the specific glimepiride/metformin combination product. The dataset also includes numerous vendor networking events (trade shows, forums, open houses) and administrative notices unrelated to pharmaceutical procurement, suggesting the code is either underutilized for its stated commodity or was incorrectly applied to opportunities spanning broader health-system purchases.

State and local jurisdictions that have posted pharmaceutical-related solicitations recently include Seminole County and the City of Tucson in Florida and Arizona; the Minnesota Multistate Cooperative Purchasing Alliance serving state and local participants across the upper Midwest and Oregon; Pinellas County, Florida (forensic drug standards, ITQ, April 2026); and Collier County, Florida (employee health clinic and wellness services, RFP, April 2026). Geographic activity concentrates in Florida and the Upper Midwest cooperative purchasing network. The code itself does not demonstrate active procurement for the specific glimepiride/metformin combination therapy; vendors pursuing this commodity should verify with state Medicaid agencies, correctional healthcare systems, and county health departments whether future solicitations will be posted under this code or under broader generic-pharmaceutical or multi-source-drug categories where the recent contract activity actually occurs.